-
-
-
-
-
-
-
Wolfe Research Assumes Veracyte, Inc (VCYT) at Outperform
-
-
-
-
-
-
-
Veracyte, Inc (VCYT) PT Lowered to $37 at Morgan Stanley
-
-
-
-
-
-
-
Veracyte, Inc (VCYT) PT Raised to $44 at Needham
-
-
-
-
-
-
-
Veracyte to present prostate cancer biomarker data at ASTRO 2025
-
-
-
-
-
-
-
Form SCHEDULE 13G/A VERACYTE, INC. Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
Veracyte (VCYT) Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
-
-
-
-
-
-
-
Veracyte (VCYT) spreaders active in December and January 50 calls
-
445,855 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

